Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Article
Lassman, Andrew B, Pugh, Stephanie L, Gilbert, Mark R et al. (2015). Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
. NEURO-ONCOLOGY, 17(7), 992-998. 10.1093/neuonc/nov011
Lassman, Andrew B, Pugh, Stephanie L, Gilbert, Mark R et al. (2015). Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
. NEURO-ONCOLOGY, 17(7), 992-998. 10.1093/neuonc/nov011
Lassman, Andrew B; Pugh, Stephanie L; Gilbert, Mark R; Aldape, Kenneth D; Geinoz, Sandrine; Beumer, Jan H; Christner, Susan M; Komaki, Ritsuko; DeAngelis, Lisa M; Gaur, Rakesh; Youssef, Emad; Wagner, Henry; Won, Minhee; Mehta, Minesh P